CXCL5 and cancer: The other phenotypic molecule identified in M‐MDSC‐like response was CXCL5, which in cancer, acts as the chemoattractant for CXCR2‐expressing MDSCs, thus promoting MDSC recruitment and infiltration into tumors.26